EUVIMEDEUVIMED entdecken
FallberichtÜbersichtsarbeitVergleichsstudieOpen Access · CC BY 4.0

Chemoradiotherapy Strategies for Immunotherapy-Sensitive Multi-Metastatic Nasopharyngeal Carcinoma: A Comparative Case Report and Literature Review

Zikun Li, Yuxiang He

Current Oncology · 2025

DOI: 10.3390/curroncol32080466 ↗

Kurz gefasst

Fallbericht in der Zeitschrift Current Oncology, 2025. Verfasst von Zikun Li und 1 weiteren Autor:innen. Beteiligte Einrichtung: Oncology Department, Xiangya Hospital Central South University, Changsha 410008, China. Hauptthemen laut MEDLINE: Nasopharyngeal Carcinoma, Chemoradiotherapy, Nasopharyngeal Neoplasms, Immunotherapy. Die Arbeit nennt 16 Literaturangaben. Der Volltext ist frei zugänglich (Open Access, CC BY 4.0).

AbstractSchlagwörterBibliografische AngabenZitierenVerwandte Studien

Abstract (Originalsprache)

This study investigates two cases of stage IVb de novo multi-metastatic nasopharyngeal carcinoma (NPC) that responded to immunotherapy but resulted in different outcomes. Case 1 involved a multi-metastatic NPC patient (T4N3M1) with extensive bone and lymphatic metastases and severely impaired physical condition (ECOG PS 2) who showed significant tumor reduction after one cycle of immunotherapy combined with non-platinum chemotherapy, with no radiation exposure. Due to financial difficulties, the patient received intermittent immunotherapy plus chemotherapy and survived 28 months with a good quality of life. Case 2 describes a multi-metastatic NPC patient (T3N2M1) with multi-organ (bone and liver) metastases and good performance status (ECOG PS 0) who underwent standard chemotherapy, immunotherapy, and radiotherapy but experienced rapid progression and died after 21 months. Immunotherapy combined with chemotherapy remains the standard for multi-metastatic NPC patients. Patients responsive to induction chemotherapy gain survival benefits from subsequent radiotherapy. However, the advantages and disadvantages of radiotherapy for immunotherapy-sensitive multi-metastatic NPC patients are still unclear. Radiotherapy (RT) can enhance local control and promote tumor antigen release, thereby complementing immunotherapy; yet it can also damage immune cells, leading to exhaustion and resistance. Therefore, balancing RT and chemotherapy is vital for optimizing immune synergy and preventing immune exhaustion.

Schlagwörter

MeSH-Schlagwörter (MEDLINE)

Nasopharyngeal CarcinomaChemoradiotherapyNasopharyngeal NeoplasmsImmunotherapyHumansMaleMiddle AgedFemale

Stichwörter der Autor:innen

immunotherapy-sensitivemulti-metastasisnasopharyngeal carcinomapalliative radiotherapy

Autor:innen und Institutionen

  • Oncology Department, Xiangya Hospital Central South University, Changsha 410008, China.

Zitieren

APA

Li, Z., & He, Y. (2025). Chemoradiotherapy Strategies for Immunotherapy-Sensitive Multi-Metastatic Nasopharyngeal Carcinoma: A Comparative Case Report and Literature Review. Current Oncology. https://doi.org/10.3390/curroncol32080466

Vancouver

Li Z, He Y. Chemoradiotherapy Strategies for Immunotherapy-Sensitive Multi-Metastatic Nasopharyngeal Carcinoma: A Comparative Case Report and Literature Review. Current Oncology. 2025. doi:10.3390/curroncol32080466

BibTeX
@article{Li2025,
  author = {Li, Zikun and He, Yuxiang},
  title = {Chemoradiotherapy Strategies for Immunotherapy-Sensitive Multi-Metastatic Nasopharyngeal Carcinoma: A Comparative Case Report and Literature Review},
  journal = {Current Oncology},
  year = {2025},
  doi = {10.3390/curroncol32080466}
}
Kostenlos starten →